Selenium overdose: Brazil nuts and the narrow therapeutic window

← Back to articles

Selenium is an essential trace mineral with a famously narrow gap between "enough" and "too much." The U.S. recommended dietary allowance for adults is 55 mcg/day, while the tolerable upper intake level (UL) is 400 mcg/day — a roughly seven-fold margin that is small by the standards of most micronutrients. For people who already eat a selenium-replete diet, adding a 200 mcg supplement plus a daily habit of selenium-dense Brazil nuts can push total intake toward or past that ceiling. A well-documented 2008 outbreak and a body of clinical-trial data show what happens when intake stays elevated.

The 2008 liquid-supplement outbreak

The clearest real-world demonstration of selenium toxicity from a supplement is the 2008 U.S. outbreak investigated by the CDC and reported by MacFarquhar and colleagues in Archives of Internal Medicine. A liquid dietary supplement was manufactured containing roughly 200 times its labeled selenium concentration; the median estimated dose consumed was about 41,749 mcg/day, against an RDA of 55 mcg/day. Investigators identified 201 cases across 10 states. The most frequently reported symptoms were diarrhea (78%), fatigue (75%), hair loss (72%), joint pain (70%), and nail discoloration or brittleness (61%). The mean initial serum selenium concentration among tested patients was 751 mcg/L, far above the reference of 125 mcg/L or less. At 90-day follow-up, more than half still had fingernail discoloration and loss, and roughly a third had persistent fatigue and hair loss [1]. The episode is a textbook illustration of how a single manufacturing error can produce a nationwide toxicity cluster — and why supplement potency control matters.

The Brazil nut question

Brazil nuts (Bertholletia excelsa) are the richest common dietary source of selenium, but their content is highly variable because it depends on the selenium concentration of the soil where the tree grew. The variability is real enough that researchers caution against treating any fixed number of nuts as a reliable dose. In a controlled trial, providing the equivalent of 55 mcg of selenium per day as Brazil nut butter raised serum selenium and selenoprotein P just as effectively as a selenium supplement [2]. In a study of Brazilian preschool children given 15–30 g of Brazil nuts three days a week, estimated selenium intake reached about 155 mcg/day and biomarkers exceeded reference ranges — intake the authors described as potentially toxic on nut days — though no clinical selenosis was observed [3]. A separate cross-sectional study of 448 adults in a high-selenium Amazonian region found blood selenium values ranging up to 1,500 mcg/L without dermal or breath signs of toxicity, which suggests that biomarker elevation precedes clinical selenosis and that the threshold for overt harm from food sources alone is high [4]. The practical point is not that a few Brazil nuts are dangerous, but that they are an unpredictable way to "top up" selenium and should not be stacked on top of a high-dose supplement.

The trial evidence: no cancer benefit, a diabetes signal

The Selenium and Vitamin E Cancer Prevention Trial (SELECT) randomized 35,533 relatively healthy men to selenium 200 mcg/day (as L-selenomethionine), vitamin E 400 IU/day, both, or placebo. Selenium did not prevent prostate or other cancers, and there was a statistically non-significant increase in type 2 diabetes in the selenium group (relative risk 1.07; 99% CI 0.94–1.22) [5]. A separate randomized trial — the Nutritional Prevention of Cancer follow-up reported by Stranges and colleagues — found that 200 mcg/day of selenium over an average of 7.7 years was associated with a significantly higher incidence of type 2 diabetes (hazard ratio 1.55; 95% CI 1.03–2.33), with the greatest risk in participants who already had the highest baseline selenium levels [6]. A Cochrane review of selenium for cancer prevention, pooling 83 studies, concluded there is no convincing evidence that selenium supplementation reduces cancer risk, and noted that supplementation increased the risk of alopecia, dermatitis, and — in men with the highest baseline selenium — high-grade prostate cancer, alongside a small increase in type 2 diabetes [7]. The mechanistic literature links chronically high selenoprotein activity to impaired insulin signaling, which is consistent with the trial signals [8].

What selenium toxicity looks like

Chronic selenosis develops over weeks to months of excess intake and produces a recognizable pattern: gastrointestinal upset, fatigue, hair loss, and characteristic nail changes (discoloration, brittleness, and shedding), sometimes with a garlic-like odor on the breath and, in more severe cases, neurological symptoms [1]. Markedly elevated serum or blood selenium supports the diagnosis. Management is straightforward in principle — remove the source and provide supportive care — and most symptoms improve over months, although nail and hair changes can be slow to resolve. Because the early signs (fatigue, GI upset) are non-specific, the cause is easily missed unless a clinician asks about supplements and selenium-rich foods.

Where supplementation is and is not justified

Adults in selenium-replete regions, which include most of North America and much of Europe, rarely need a selenium supplement; typical diets already supply adequate amounts, and the trial data give no reason to add more for general "antioxidant" or cancer-prevention purposes. Genuine deficiency does occur — for example in regions with selenium-poor soil, in some patients on long-term parenteral nutrition, and in specific malabsorptive states — and is treated under medical supervision. The prudent ceiling for healthy adults remains the 400 mcg/day UL, counting supplements and selenium-dense foods together. In practice that means a multivitamin supplying 55–100 mcg is generally fine, but a 200 mcg high-potency selenium product taken alongside daily Brazil nuts is the kind of combination that has produced biomarker elevations and, historically, clinical harm.

Sources

1. MacFarquhar JK, Broussard DL, Melstrom P, et al. "Acute selenium toxicity associated with a dietary supplement." Arch Intern Med, 2010;170(3):256-61. PMID 20142570.
2. Simon R, Lossow K, Pellowski D, et al. "Improving the selenium supply of vegans and omnivores with Brazil nut butter compared to a dietary supplement in a randomized controlled trial." Eur J Nutr, 2025;64(2):74. PMID 39891729.
3. Martens IBG, Cardoso BR, Hare DJ, et al. "Selenium status in preschool children receiving a Brazil nut-enriched diet." Nutrition, 2015;31(11-12):1339-43. PMID 26429652.
4. Lemire M, Philibert A, Fillion M, et al. "No evidence of selenosis from a selenium-rich diet in the Brazilian Amazon." Environ Int, 2012;40:128-36. PMID 21856002.
5. Lippman SM, Klein EA, Goodman PJ, et al. "Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)." JAMA, 2009;301(1):39-51. PMID 19066370.
6. Stranges S, Marshall JR, Natarajan R, et al. "Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial." Ann Intern Med, 2007;147(4):217-23. PMID 17620655.
7. Vinceti M, Filippini T, Del Giovane C, et al. "Selenium for preventing cancer." Cochrane Database Syst Rev, 2018;1(1):CD005195. PMID 29376219.
8. Zhou J, Huang K, Lei XG. "Selenium and diabetes--evidence from animal studies." Free Radic Biol Med, 2013;65:1548-1556. PMID 23867154.